Article Text

Download PDFPDF
Future-proofing pathology part 2: building a business case for digital pathology
  1. Bethany Jill Williams1,2,
  2. David Bottoms3,
  3. David Clark4,
  4. Darren Treanor1,2
  1. 1 Department of Histopathology, St James’s University Hospital, Leeds, UK
  2. 2 University of Leeds, Leeds, UK
  3. 3 North of England Clinical Networks, NHS England, Richmond, UK
  4. 4 Path Links, North Lincolnshire and Goole NHS Trust, Lincolnshire, UK
  1. Correspondence to Dr Bethany Jill Williams, Department of Histopathology, St James’s University Hospital, Leeds LS9 7TF, UK; bethany.williams2{at}


Diagnostic histopathology departments are experiencing unprecedented economic and service pressures, and many institutions are now considering digital pathology as part of the solution. In this document, a follow on to our case for adoption report, we provide information and advice to help departments create their own clear, succinct, individualised business case for the clinical deployment of digital pathology.

  • digital pathology
  • management
  • laboratory management
  • information technology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Dhirendra Govender.

  • Contributors BJW wrote and edited article, and provided content. DC and DB provided content. DT provided content and reviewed the article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Author note Leeds Teaching Hospitals NHS Trust has a collaborative partnership with Leica Biosystems.